| scholarly article | Q13442814 |
| P50 | author | Robert J. Hilsden | Q45901259 |
| P2093 | author name string | Robert P Myers | |
| Hude Quan | |||
| Andrew Fong | |||
| Kelly W Burak | |||
| Abdel Aziz M Shaheen | |||
| Mark G Swain | |||
| Lloyd Sutherland | |||
| Alex Wan | |||
| P2860 | cites work | Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years | Q34932835 |
| The burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004. | Q37144257 | ||
| Recent advances in the epidemiology of primary biliary cirrhosis | Q37154306 | ||
| Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) | Q39859200 | ||
| Epidemiology and natural history of primary biliary cirrhosis in a US community | Q40735092 | ||
| The geoepidemiology of primary biliary cirrhosis | Q40904961 | ||
| Transplantation trends in primary biliary cirrhosis. | Q42632785 | ||
| Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid | Q43483632 | ||
| The demography of primary biliary cirrhosis in Ontario, Canada | Q44439436 | ||
| Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients | Q44617739 | ||
| Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations | Q45010914 | ||
| The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis | Q45024371 | ||
| Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment | Q45074381 | ||
| Proof of principal studies to assess the role of the human betaretrovirus in patients with primary biliary cirrhosis | Q45168082 | ||
| The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis | Q45247238 | ||
| A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue | Q46509129 | ||
| Mortality attributable to cholestatic liver disease in the United States. | Q46719878 | ||
| Relationship between hospital volume and outcomes of esophageal variceal bleeding in the United States. | Q51117728 | ||
| Predicting in-hospital mortality in patients with cirrhosis: results differ across risk adjustment methods. | Q51859962 | ||
| Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. | Q55044287 | ||
| Primary biliary cirrhosis | Q56428273 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group | Q77807948 | ||
| Prevalence of autoimmune liver disease in Alaska Natives | Q78309924 | ||
| Natural history of primary biliary cirrhosis | Q81213642 | ||
| Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites | Q82639990 | ||
| Nonparametric Estimation from Incomplete Observations | Q25938997 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Validation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data | Q31131808 | ||
| Primary biliary cirrhosis once rare, now common in the United Kingdom? | Q33869156 | ||
| Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients | Q34462959 | ||
| The epidemiology of primary biliary cirrhosis: a survey of mortality in England and Wales | Q34476962 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| primary biliary cholangitis | Q1072420 | ||
| P304 | page(s) | 1884-1892 | |
| P577 | publication date | 2009-12-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. | |
| P478 | volume | 50 |
| Q93190745 | A National Hospital-Based Study of Hospitalized Patients With Primary Biliary Cholangitis |
| Q36729456 | A study of the effects of saliva stimulation by nizatidine on dry mouth symptoms of primary biliary cirrhosis |
| Q33751665 | Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis |
| Q64234389 | Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States |
| Q93140801 | Changing epidemiology and natural history of primary biliary cirrhosis |
| Q37546867 | Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort |
| Q34490300 | Current and Future Burden of Chronic Nonmalignant Liver Disease |
| Q61448408 | Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis |
| Q36755979 | Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. |
| Q38600118 | Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015. |
| Q90269685 | Epidemiology and clinical course of primary biliary cholangitis in the Asia-Pacific region: a systematic review and meta-analysis |
| Q60301070 | Epidemiology and liver transplantation burden of primary biliary cholangitis: a retrospective cohort study |
| Q38565478 | Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity |
| Q36914749 | Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis |
| Q39213467 | Geoepidemiology and changing mortality in primary biliary cholangitis |
| Q48086460 | Geoepidemiology and space-time analysis of Primary biliary cirrhosis in Crete, Greece. |
| Q47205297 | Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland. |
| Q35681241 | Incidence and prevalence of dementia in linked administrative health data in Saskatchewan, Canada: a retrospective cohort study |
| Q35155090 | Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease. |
| Q40707802 | Low incidence and prevalence of primary biliary cirrhosis in Canterbury, New Zealand: a population-based study. |
| Q47567609 | Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history. |
| Q54248274 | Mortality and the risk of malignancy in autoimmune liver diseases: A population-based study in Canterbury, New Zealand |
| Q37564713 | National incidence of autoimmune liver diseases and its relationship with the human development index. |
| Q34623557 | Pathogenesis of Cholestatic Liver Disease and Therapeutic Approaches |
| Q38738566 | Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. |
| Q24186852 | Pharmacological treatments for primary biliary cirrhosis: a network meta-analysis |
| Q38622901 | Population-based epidemiology of primary biliary cirrhosis in South Korea. |
| Q33683969 | Prevalence of primary biliary cirrhosis in adults referring hospital for annual health check-up in Southern China |
| Q57114658 | Primary Biliary Cholangitis in Medicare Population: The Impact on Mortality and Resource Utilization |
| Q46078221 | Primary biliary cholangitis: a comprehensive overview |
| Q36599248 | Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis |
| Q35609106 | Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. |
| Q28076353 | Recent advances in the diagnosis and treatment of primary biliary cholangitis |
| Q36637728 | Risk factors for hepatic decompensation in patients with primary biliary cirrhosis |
| Q35442766 | Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study |
| Q34992322 | Role of sex hormones in the modulation of cholangiocyte function. |
| Q38390677 | Scandinavian epidemiological research in gastroenterology and hepatology |
| Q52624982 | The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. |
| Q59130562 | The Geoepidemiology of Autoimmune Liver Disease |
| Q64268682 | The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study |
| Q33810066 | The feasibility and reliability of transient elastography using Fibroscan®: a practice audit of 2335 examinations |
| Q54976907 | The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes. |
| Q30993162 | Validation of coding algorithms for the identification of patients hospitalized for alcoholic hepatitis using administrative data. |
| Q36301142 | Xenobiotics and autoimmunity: does acetaminophen cause primary biliary cirrhosis? |
| Q26772312 | Xenobiotics and loss of tolerance in primary biliary cholangitis |
Search more.